Market Cap 5.51M
Revenue (ttm) 15.23M
Net Income (ttm) -28.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -188.84%
Debt to Equity Ratio 0.00
Volume 8,700
Avg Vol 5,212
Day's Range N/A - N/A
Shares Out 1.00M
Stochastic %K 59%
Beta -0.05
Analysts Sell
Price Target $119.94

Company Profile

Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.

Industry: Medical Devices
Sector: Healthcare
Phone: 508 647 4000
Address:
11 Huron Drive, Natick, United States
Latest News on ALURD
No data available.